138 related articles for article (PubMed ID: 17363688)
21. Glutaredoxin 2a overexpression in macrophages promotes mitochondrial dysfunction but has little or no effect on atherogenesis in LDL-receptor null mice.
Zamora DA; Downs KP; Ullevig SL; Tavakoli S; Kim HS; Qiao M; Greaves DR; Asmis R
Atherosclerosis; 2015 Jul; 241(1):69-78. PubMed ID: 25966442
[TBL] [Abstract][Full Text] [Related]
22. Macrophage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development.
Vikstedt R; Ye D; Metso J; Hildebrand RB; Van Berkel TJ; Ehnholm C; Jauhiainen M; Van Eck M
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):578-86. PubMed ID: 17170377
[TBL] [Abstract][Full Text] [Related]
23. BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis.
Singh KK; Shukla PC; Quan A; Al-Omran M; Lovren F; Pan Y; Brezden-Masley C; Ingram AJ; Stanford WL; Teoh H; Verma S
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):949-960.e4. PubMed ID: 23415688
[TBL] [Abstract][Full Text] [Related]
24. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
Stachon P; Peikert A; Michel NA; Hergeth S; Marchini T; Wolf D; Dufner B; Hoppe N; Ayata CK; Grimm M; Cicko S; Schulte L; Reinöhl J; von zur Muhlen C; Bode C; Idzko M; Zirlik A
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2237-45. PubMed ID: 25104800
[TBL] [Abstract][Full Text] [Related]
25. Role of the macrophage very-low-density lipoprotein receptor in atherosclerotic lesion development.
Eck MV; Oost J; Goudriaan JR; Hoekstra M; Hildebrand RB; Bos IS; van Dijk KW; Van Berkel TJ
Atherosclerosis; 2005 Dec; 183(2):230-7. PubMed ID: 15979629
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrial Oxidative Stress Promotes Atherosclerosis and Neutrophil Extracellular Traps in Aged Mice.
Wang Y; Wang W; Wang N; Tall AR; Tabas I
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):e99-e107. PubMed ID: 28596373
[TBL] [Abstract][Full Text] [Related]
27. Macrophage-specific overexpression of interleukin-5 attenuates atherosclerosis in LDL receptor-deficient mice.
Zhao W; Lei T; Li H; Sun D; Mo X; Wang Z; Zhang K; Ou H
Gene Ther; 2015 Aug; 22(8):645-52. PubMed ID: 25871825
[TBL] [Abstract][Full Text] [Related]
28. Effect of bone marrow transplantation on lipoprotein metabolism and atherosclerosis in LDL receptor-knockout mice.
Herijgers N; Van Eck M; Groot PH; Hoogerbrugge PM; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):1995-2003. PubMed ID: 9351364
[TBL] [Abstract][Full Text] [Related]
29. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445
[TBL] [Abstract][Full Text] [Related]
30. Leukocyte transglutaminase 2 expression limits atherosclerotic lesion size.
Boisvert WA; Rose DM; Boullier A; Quehenberger O; Sydlaske A; Johnson KA; Curtiss LK; Terkeltaub R
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):563-9. PubMed ID: 16410462
[TBL] [Abstract][Full Text] [Related]
31. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
[TBL] [Abstract][Full Text] [Related]
32. Enhanced atherosclerosis in TIPE2-deficient mice is associated with increased macrophage responses to oxidized low-density lipoprotein.
Lou Y; Liu S; Zhang C; Zhang G; Li J; Ni M; An G; Dong M; Liu X; Zhu F; Zhang W; Gao F; Chen YH; Zhang Y
J Immunol; 2013 Nov; 191(9):4849-57. PubMed ID: 24081993
[TBL] [Abstract][Full Text] [Related]
33. Retrovirus-mediated expression of apolipoprotein A-I in the macrophage protects against atherosclerosis in vivo.
Ishiguro H; Yoshida H; Major AS; Zhu T; Babaev VR; Linton MF; Fazio S
J Biol Chem; 2001 Sep; 276(39):36742-8. PubMed ID: 11477092
[TBL] [Abstract][Full Text] [Related]
34. Induction of oxidative stress by oxidized LDL via meprinα-activated epidermal growth factor receptor in macrophages.
Gao P; Wang XM; Qian DH; Qin ZX; Jin J; Xu Q; Yuan QY; Li XJ; Si LY
Cardiovasc Res; 2013 Mar; 97(3):533-43. PubMed ID: 23250920
[TBL] [Abstract][Full Text] [Related]
35. Cyclooxygenase-1 deficiency in bone marrow cells increases early atherosclerosis in apolipoprotein E- and low-density lipoprotein receptor-null mice.
Babaev VR; Ding L; Reese J; Morrow JD; Breyer MD; Dey SK; Fazio S; Linton MF
Circulation; 2006 Jan; 113(1):108-17. PubMed ID: 16380543
[TBL] [Abstract][Full Text] [Related]
36. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis.
Ishigaki Y; Katagiri H; Gao J; Yamada T; Imai J; Uno K; Hasegawa Y; Kaneko K; Ogihara T; Ishihara H; Sato Y; Takikawa K; Nishimichi N; Matsuda H; Sawamura T; Oka Y
Circulation; 2008 Jul; 118(1):75-83. PubMed ID: 18559699
[TBL] [Abstract][Full Text] [Related]
37. Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells.
Vendrov AE; Hakim ZS; Madamanchi NR; Rojas M; Madamanchi C; Runge MS
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2714-21. PubMed ID: 17823367
[TBL] [Abstract][Full Text] [Related]
38. Intermedin inhibits macrophage foam-cell formation via tristetraprolin-mediated decay of CD36 mRNA.
Dai XY; Cai Y; Sun W; Ding Y; Wang W; Kong W; Tang C; Zhu Y; Xu MJ; Wang X
Cardiovasc Res; 2014 Feb; 101(2):297-305. PubMed ID: 24253523
[TBL] [Abstract][Full Text] [Related]
39. Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants.
Aviram M
Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):599-608. PubMed ID: 8877334
[TBL] [Abstract][Full Text] [Related]
40. Preliminary evaluation of a self-complementary AAV2/8 vector for hepatic gene transfer of human apoE3 to inhibit atherosclerotic lesion development in apoE-deficient mice.
Osman E; Evans V; Graham IR; Athanasopoulos T; McIntosh J; Nathwani AC; Simons JP; Dickson G; Owen JS
Atherosclerosis; 2009 May; 204(1):121-6. PubMed ID: 18930458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
